|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-2-14
|
|
pubmed:abstractText |
Breast cancer is composed of phenotypically diverse populations of cancer cells. The ability to form breast tumors has been shown by in vitro/in vivo studies to be restricted to epithelial tumor cells with CD44(+)/CD24(-/low) characteristics. Validation of these findings with respect to detection in clinical samples, prognosis, and clinical relevance is in demand.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anthracyclines,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD24,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD44,
http://linkedlifedata.com/resource/pubmed/chemical/CD24 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1154-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15709183-Adult,
pubmed-meshheading:15709183-Aged,
pubmed-meshheading:15709183-Aged, 80 and over,
pubmed-meshheading:15709183-Anthracyclines,
pubmed-meshheading:15709183-Antigens, CD,
pubmed-meshheading:15709183-Antigens, CD24,
pubmed-meshheading:15709183-Antigens, CD44,
pubmed-meshheading:15709183-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15709183-Breast Neoplasms,
pubmed-meshheading:15709183-Combined Modality Therapy,
pubmed-meshheading:15709183-Female,
pubmed-meshheading:15709183-Humans,
pubmed-meshheading:15709183-Immunohistochemistry,
pubmed-meshheading:15709183-Membrane Glycoproteins,
pubmed-meshheading:15709183-Middle Aged,
pubmed-meshheading:15709183-Neoplasm Metastasis,
pubmed-meshheading:15709183-Prognosis,
pubmed-meshheading:15709183-Survival Analysis,
pubmed-meshheading:15709183-Tamoxifen,
pubmed-meshheading:15709183-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.
|
|
pubmed:affiliation |
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, D-70376 Stuttgart, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
